DowDuPont has a successful business as an industry leader in agrichemicals and transgenic crop trait innovation. Since 2015, the company has been taking significant, strategic steps to establish a dominant presence in the field of crop trait development through genome editing, focusing on the CRISPR system to do so. DowDuPont's IP portfolio, built through a series of in-licensing and cross-licensing agreements, is the most robust in the agriculture industry for crop trait development and has led to the development of additional improvements in the functionality of CRISPR systems, including the ability to map off-target activity, which has been a key concern for the future safety of CRISPR applications in both crops and human health.
Contact us to learn the benefits of becoming a Lux member.
Or call us now
For North America (Boston Headquarters)
+1 (617) 502-5300
For EMEA (Amsterdam)
+31 20 280 7900
For APAC (Singapore)